202 related articles for article (PubMed ID: 26267417)
1. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients.
Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Oquendo MA; Vieta E; Benabarre A
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1452-62. PubMed ID: 23453640
[TBL] [Abstract][Full Text] [Related]
3. Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.
Iwahashi K; Nishizawa D; Narita S; Numajiri M; Murayama O; Yoshihara E; Onozawa Y; Nagahori K; Fukamauchi F; Ikeda K; Ishigooka J
Clin Neuropharmacol; 2014; 37(4):108-10. PubMed ID: 24992082
[TBL] [Abstract][Full Text] [Related]
4. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
[TBL] [Abstract][Full Text] [Related]
5. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
[TBL] [Abstract][Full Text] [Related]
6. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.
Adli M; Hollinde DL; Stamm T; Wiethoff K; Tsahuridu M; Kirchheiner J; Heinz A; Bauer M
Biol Psychiatry; 2007 Dec; 62(11):1295-302. PubMed ID: 17628506
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
Lin YF; Huang MC; Liu HC
J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
[TBL] [Abstract][Full Text] [Related]
8. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
9. Association between GSK3β gene and increased impulsivity in bipolar disorder.
Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Ruíz V; Pérez A; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):510-8. PubMed ID: 24486183
[TBL] [Abstract][Full Text] [Related]
10. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T; Yamada K; Ohba H; Iwayama Y; Toyota T; Hattori E; Inada T; Kunugi H; Tatsumi M; Ozaki N; Iwata N; Sakamoto K; Iijima Y; Iwata Y; Tsuchiya KJ; Sugihara G; Nanko S; Osumi N; Detera-Wadleigh SD; Kato T; Yoshikawa T
Neuropsychopharmacology; 2007 Aug; 32(8):1727-37. PubMed ID: 17251911
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
[TBL] [Abstract][Full Text] [Related]
12. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
Dimitrova A; Milanova V; Krastev S; Nikolov I; Toncheva D; Owen MJ; Kirov G
Pharmacogenomics J; 2005; 5(1):35-41. PubMed ID: 15505643
[TBL] [Abstract][Full Text] [Related]
13. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
Bloch PJ; Weller AE; Doyle GA; Ferraro TN; Berrettini WH; Hodge R; Lohoff FW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1515-9. PubMed ID: 20800640
[TBL] [Abstract][Full Text] [Related]
14. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
15. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
16. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
[TBL] [Abstract][Full Text] [Related]
17. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2.
Ohnishi T; Watanabe A; Ohba H; Iwayama Y; Maekawa M; Yoshikawa T
Neurosci Res; 2010 May; 67(1):86-94. PubMed ID: 20153384
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of lithium response depends upon clinical co-morbidity.
Bremer T; Diamond C; McKinney R; Shehktman T; Barrett TB; Herold C; Kelsoe JR
Mol Diagn Ther; 2007; 11(3):161-70. PubMed ID: 17570738
[TBL] [Abstract][Full Text] [Related]
19. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
